Apyx Medical (APYX) Set to Announce Earnings on Thursday

Apyx Medical (NASDAQ:APYX) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Apyx Medical has set its FY 2024 guidance at EPS.Investors interested in participating in the company’s conference call can do so using this link.

Apyx Medical (NASDAQ:APYX) last released its quarterly earnings results on Thursday, March 21st. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.06). The company had revenue of $14.66 million for the quarter, compared to analyst estimates of $14.40 million. Apyx Medical had a negative return on equity of 54.90% and a negative net margin of 35.75%. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Apyx Medical Trading Down 2.1 %

APYX opened at $1.40 on Thursday. Apyx Medical has a 12-month low of $1.21 and a 12-month high of $7.97. The company has a debt-to-equity ratio of 1.23, a current ratio of 5.52 and a quick ratio of 4.74. The stock has a market capitalization of $48.50 million, a PE ratio of -2.59 and a beta of 1.09. The firm’s fifty day moving average price is $1.62 and its 200 day moving average price is $2.09.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.